CDA Formulations to Remove Cancer as the Top Killers of Many Asian Countries

The objective of this article is to rectify cancer therapies which are apparently inadequate to result in cancer as the top killer of the people of many Asian countries for a very long time. Cancer therapy had a bad start to rely on toxic chemicals to kill cancer cells (CCs), which was a mistake made at a time when we did not have a complete knowledge of cancer. Cancer stem cells (CSCs) became known in 1997. The discovery of CSCs unraveled a very important issue of cancer. It became evident that, although CSCs constituted only a small subpopulation, these cells were responsible for the initiation of tumor growth and the treatment failure. Thus, the success of cancer therapy depends on the elimination of CSCs. Our studies on abnormal methylation enzymes (MEs), chemo-surveillance, wound healing and cell differentiation agent (CDA) formulations are very closely related to the issue of CSCs. Thus, we are in a unique position to offer the best solution of CSCs. Cancer evolves due to wound unhealing. Chemo-surveillance is the creation of the nature to ensure perfection of wound healing. Chemo-surveillance is specifically destroyed in cancer patients. Restoration of chemo-surveillance offers excellent therapy of cancer. CDA-2 was a preparation of wound healing metabolites purified from urine which has been approved by the Chinese FDA for the therapy of cancer and myelodysplastic syndromes (MDSs). MDSs are diseases attributable entirely to CSCs. CDA-2 was demonstrably the best drug for the therapy of MDSs. CDA formulations are the creation of the nature to remove cancer as the top killer of the people of Asian countries.